Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-05 @ 5:39 PM
Study NCT ID:
NCT05459532
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2022-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa
Sponsor:
University of Witwatersrand, South Africa
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-13
First Submit QC Date:
None
Study First Post Date:
2022-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-01
Last Update Post Date Type:
ACTUAL